Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCardiovascular
Open Access

Amphetamine-like Neurochemical and Cardiovascular Effects of α-Ethylphenethylamine Analogs Found in Dietary Supplements

Charles W. Schindler, Eric B. Thorndike, John S. Partilla, Kenner C. Rice and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 118-126; DOI: https://doi.org/10.1124/jpet.120.000129
Charles W. Schindler
Designer Drug Research Unit (C.W.S., J.S.P., M.H.B.) and Preclinical Pharmacology Section (C.W.S., E.B.T.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute of Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric B. Thorndike
Designer Drug Research Unit (C.W.S., J.S.P., M.H.B.) and Preclinical Pharmacology Section (C.W.S., E.B.T.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute of Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. Partilla
Designer Drug Research Unit (C.W.S., J.S.P., M.H.B.) and Preclinical Pharmacology Section (C.W.S., E.B.T.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute of Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenner C. Rice
Designer Drug Research Unit (C.W.S., J.S.P., M.H.B.) and Preclinical Pharmacology Section (C.W.S., E.B.T.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute of Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael H. Baumann
Designer Drug Research Unit (C.W.S., J.S.P., M.H.B.) and Preclinical Pharmacology Section (C.W.S., E.B.T.), National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland and Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute of Alcohol Abuse and Alcoholism Intramural Research Programs, Rockville, Maryland (K.C.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Chemical structures of AEPEA, MEPEA, and DEPEA as compared with amphetamine and methamphetamine.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effects of amphetamine and PEA analogs on inhibition of uptake and stimulation of efflux (i.e., release) at DAT (upper panels) or NET (lower panels) in rat brain synaptosomes. For uptake assays, synaptosomes were incubated with different concentrations of test drugs in the presence of 5 nM [3H]dopamine ([3H]DA) or [3H]norepinephrine ([3H]NE). Data are means ± S.D., expressed as a percentage of transmitter uptake for N = 3 experiments performed in triplicate. For release assays, synaptosomes were preloaded with 9 nM [3H]MPP+ and then incubated with different concentrations of test drugs to evoke release via reverse transport. Data are means ± S.D., expressed as a percentage of [3H]MPP+ release for three experiments performed in triplicate.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effects of GBR12909 (GBR) or desipramine (DMI) on drug-induced release of [3H]MPP+ at DAT (upper panels) or NET (lower panels). For substrate reversal assays, synaptosomes were preloaded with 9 nM [3H]MPP+, and then test drugs were incubated with or without GBR12909 (1 nM) for DAT assays or desipramine (8 nM) for the NET assays. Data are means ± S.D. expressed as a percentage of [3H]MPP+ release for three experiments performed in triplicate.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Time course effects of AEPEA administration on BP, HR, motor activity, and core body temperature. Male rats bearing biotelemetry transponders received subcutaneous injection of 1, 3, or 10 mg/kg AEPEA or its saline vehicle and were returned to their home cages. Five minutes later, cages were placed atop telemetric receivers. Data were collected in 10-minute epochs for 3 hours. Data are expressed as means ± S.E.M. for five rats per group.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Dose-effect functions for amphetamine (Amph) and PEA analogs on BP, HR, motor activity, and core body temperature. Data represent mean values across the full 3-hour session. Solid symbols indicate significant differences from the respective saline group. Data are means ± S.E.M. for five rats per group.

Tables

  • Figures
    • View popup
    TABLE 1

    Effects of amphetamine and PEA analogs on the uptake of [3H]neurotransmitters and on the release of [3H]MPP+ at DAT or NET in rat brain synaptosomes

    Data are means ± S.D. for N = 3 experiments performed in triplicate. %Emax is defined as the percentage of maximal releasing response induced by 10 µM tyramine. DAT/NET ratio = (DAT IC50−1)/(NET IC50−1); higher value indicates greater DAT selectivity.

    DrugUptake Inhibition at DAT [IC50 (nM)]Uptake Inhibition at NET [IC50 (nM)]DAT/NET Ratio
    Amphetamine122 ± 1269 ± 90.56
    AEPEA3366 ± 333573 ± 780.16
    MEPEA2248 ± 245503 ± 950.22
    DEPEA510 ± 38427 ± 600.84
    Release at DAT EC50 (nM) (%Emax)Release at NET EC50 (nM) (%Emax)
    Amphetamine5 ± 1 (102)8 ± 1 (96)1.6
    AEPEA273 ± 36 (101)80 ± 17 (100)0.29
    MEPEA179 ± 25 (101)58 ± 12 (96)0.32
    DEPEA604 ± 159 (43)209 ± 35 (82)0.35
    • View popup
    TABLE 2

    G Protein–coupled receptorome screening for amphetamine and PEA analogsa

    Data represent Ki (nanomolar) values obtained from nonlinear regression using the Cheng-Prusoff equation when inhibition was >50%. The results for amphetamine (AMPH) were reported previously (Schindler et al., 2019).

    AMPHAEPEAMEPEADEPEA
    Serotonin
     5-HT1A2625>10,00019661588
     5-HT2B971>10,000>10,000>10,000
    Norepinephrine
     α2A420>10,000>10,000>10,000
     α2B19213624111013
     α2C171140418052320
     NET31>10,000>10,000108
    Dopamine
     DAT>10,000>10,000>10,000124
    Sigma
     σ2>10,000>10,0008061352
    Histamine
     H1>10,00025415800>10,000
    • ↵a Ki values for the following receptors were >10,000 nM for all four drugs tested: serotonin receptors 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6, 5-HT7, and SERT; norepinephrine receptors α1A, α1B, α1D, β1, β2, and β3; dopamine D1, D2, D3, D4, and D5; histamine receptors H2, H3, and H4; opioid receptors μ, κ, and δ; muscarinic receptors M1, M2, M3, M4, and M5; σ1 receptor; benzodiazepine and peripheral benzodiazepine receptors.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 376 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 376, Issue 1
1 Jan 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Amphetamine-like Neurochemical and Cardiovascular Effects of α-Ethylphenethylamine Analogs Found in Dietary Supplements
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCardiovascular

Amphetaminelike Effects of α-Ethylphenethylamine Analogs

Charles W. Schindler, Eric B. Thorndike, John S. Partilla, Kenner C. Rice and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics January 1, 2021, 376 (1) 118-126; DOI: https://doi.org/10.1124/jpet.120.000129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCardiovascular

Amphetaminelike Effects of α-Ethylphenethylamine Analogs

Charles W. Schindler, Eric B. Thorndike, John S. Partilla, Kenner C. Rice and Michael H. Baumann
Journal of Pharmacology and Experimental Therapeutics January 1, 2021, 376 (1) 118-126; DOI: https://doi.org/10.1124/jpet.120.000129
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • β3-Agonist Improves Myocardial Stiffness
  • A Novel Inhibitor of Myocardial mPTP
  • Chemotherapy and Diastolic Dysfunction
Show more Cardiovascular

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics